Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00807365 · ClinicalTrials.gov registry record · Phase 2
Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00807365: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT00807365 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00807365, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effect of a naturally occurring hormone, called Growth Hormone Releasing Hormone (GHRH), on the muscle, bone and fat tissues of the body. GHRH stimulates the production of growth hormone (GH), which regulates the build up of many tissues in the body, including muscles and bones. Many elderly people have low levels of GH. The overall goal of this research is to determine the effectiveness of GHRH to raise levels of GH and improve these body tissues. The purpose of the tests is to measure how the body handles sugar, fat, and proteins. GH can affect your body's use of sugar, fat and proteins.
Interventions
- DRUG GHRH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2007-12-17 |
| Est. Completion | 2010-04-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00807365
The ClinicalTrials.gov registry entry for NCT00807365 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GHRH is the first listed.
NCT00807365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00807365 about?
NCT00807365 is a clinical study titled "Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly". The purpose of the study is to evaluate the effect of a naturally occurring hormone, called Growth Hormone Releasing Hormone (GHRH), on the muscle, bone and fat tissues of the body. GHRH stimulates the production of growth hormone (GH), which regulates the build up of many tissues in the body, inclu...
What is the current status of trial NCT00807365?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2007-12-17. Estimated completion is 2010-04-29.
What interventions are being tested in trial NCT00807365?
The interventions under investigation include: GHRH (DRUG).
Who is sponsoring clinical trial NCT00807365?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.